Home › Pamela J. Craig and Dr. Paul B. Rothman Elected to Merck Board of Directors
 

Keywords :   


Pamela J. Craig and Dr. Paul B. Rothman Elected to Merck Board of Directors

2015-07-28 22:15:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that Pamela J. Craig, retired chief financial officer of Accenture, and Dr. Paul B. Rothman, dean of the medical faculty, vice president for medicine of The Johns Hopkins University and chief executive officer of Johns Hopkins Medicine, will join the companys board of directors, effective Sept. 1, 2015. Language: English Contact: MerckMedia Contacts:Lainie Keller, 908-236-5036orInvestor Contacts:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: of board paul directors

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.06Apple in breach of law on App Store, says EU
24.06Atlantic Tropical Weather Outlook
24.06Eastern North Pacific Tropical Weather Outlook
24.06Parties ignoring 'painful' tax and spending choices, says think tank
24.06Atlantic Tropical Weather Outlook
24.06Eastern North Pacific Tropical Weather Outlook
24.06Criminal charges recommended against Boeing - reports
24.06Grounded flights rearranged after airport chaos
More »